IO Biotech (IOBT) Live Share Price, Invest From India

IO Biotech Stock Performance

as on April 7, 2026 at 6:59 am IST

Day's Low
Day's High
$0.03
Day's Price Range
$0.06
$0.05
40.00%
Downside
20.00%
Upside
52 Week's Low
52 Week's High
$0.03
52-Week Price Range
$1.07
$0.05
44.60%
Downside
2040.00%
Upside

IO Biotech share price movements today

Previous Close: $0.03
Open: $0.03
Volume: 259.7M
Day's Low - High: $0.03 - $0.06
52 Week Low - High: $0.03 - $1.07

IO Biotech Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

IO Biotech Stock Fundamentals & Key Indicators

Check IO Biotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

0.00

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

IO Biotech vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of IO Biotech with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
IO Biotech	Buy	$-	NA	NA	0.00%	0.00%
Alnylam Pharma	StrongBuy	$30.3B	45.65%	37.18	79.72%	0.00%
Vertex Pharmaceuticals	StrongBuy	$134.2B	192.00%	30.58	86.04%	0.00%
BeOne Medicines	StrongBuy	$41.6B	NA	25.18	87.82%	0.00%
Regeneron	Buy	$83.7B	27.94%	19.42	84.86%	0.45%

Analyst Recommendation on IO Biotech Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for IO Biotech. Average target price of $2.18

IO Biotech Share Price Target

Get share price movements and forecasts by analysts on IO Biotech.

What analysts predicted

97.71%UPSIDE

Target Price

$2.18

Current Price

$0.05

Analyzed by

12 Analysts

Target

$2.18

IO Biotech target price $2.18, a slight upside of 97.71% compared to current price of $0.05. According to 12 analysts rating.

IO Biotech Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	1	-	-	-	0	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-21	-21	-26	-19	-20	-24	-31	-22	-26	-8
Net Profit Margin	0.00%	0.00%	-2358.74%	0.00%	0.00%	0.00%	-3686.24%	0.00%	0.00%	0.00%

IO Biotech Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	0	0	0
Operating Income	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-
Net Income	-10	-12	-67	-71	-86	-95
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in IO Biotech

Check out the Institutions with significant holdings in IO Biotech.

Funds	Holdings
Novo A/S	3.49%
Bridgeway Capital Management, LLC	0.10%
TWO SIGMA SECURITIES, LLC	0.06%
Partner Fund Management LP	2.99%
Geode Capital Management, LLC	0.05%

See all

Insights on IO Biotech

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 30.3% return, outperforming this stock by 128.6%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 40.9% return, outperforming this stock by 137.4%
NEGATIVE IMPACT
Price Dip
In the last 7 days, IOBT stock has moved down by -45.0%

About IO Biotech

IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.

Organisation

IO Biotech

FAQs

What is IO Biotech share price today?

IO Biotech share price today is $0.05 as on April 7, 2026 at 1:29 am IST at the close of the market. IO Biotech share today touched a day high of $0.06 and a low of $0.03.

What is the 52 week high and 52 week low for IO Biotech share?

IO Biotech share touched a 52 week high of $1.07 on October 31, 2025 and a 52 week low of $0.03 on April 6, 2026. IO Biotech stock price today i.e. April 7, 2026 at 1:29 am IST is closed at $0.05,which is 95.33% down from its 52 week high and 80.51% up from its 52 week low.

How to invest in IO Biotech Stock (IOBT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for IO Biotech on INDmoney app. Click on Buy button.

What is the minimum amount required to buy IO Biotech Stock (IOBT) from India?

Indian investors can start investing in IO Biotech (IOBT) shares with as little as ₹94.94999694824219 or $1 (as of October 31, 2026 at 2:35 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in IO Biotech stock (as per the Rupee-Dollar exchange rate as on October 31, 2026 at 2:35 am IST). Based on IO Biotech share’s latest price of $0.05 as on April 7, 2026 at 1:29 am IST, you will get 200.0000 shares of IO Biotech. Learn more about fractional shares .